-
1.
公开(公告)号:EP2858642A1
公开(公告)日:2015-04-15
申请号:EP13800188.8
申请日:2013-06-05
IPC分类号: A61K31/355 , A61K31/445 , A61K31/575 , A61P31/12
CPC分类号: C07D405/12 , C07D211/46 , C07D401/12 , C07J43/003
摘要: Iminosugar compounds are described that have inbuilt delivery features by virtue of covalent incorporation of a tocopherol moiety, or alternative moieties that are analogs of tocopherol or select analogs of cholesterol, or its antagonist “Ezitimibe”; and are likely to have broad spectrum antiviral activity. The compounds differ from previous iminosugar compounds, even lipophillic ones, being more hydrophobic and resembling fats and oils in their partition behavior in vivo into lipid phases of lipoproteins, cellular lipid droplet organelles and biological membranes. These features confer a number of unique delivery attributes in vivo, favorable to the therapy of virus infections involving cells of the lymphoid system and the liver, in particular, but these features are also favorable in general for the treatment of virus infections of man and animals.
摘要翻译: 描述了通过共价引入生育酚部分或作为生育酚类型或胆固醇的选择性类似物或其拮抗剂“依泽替米贝”的替代部分具有内含递送特征的亚氨基缩寡核苷酸化合物; 并且可能具有广谱抗病毒活性。 这些化合物与以前的亚氨基硫糖化合物不同,甚至是脂肪细胞的化合物,更疏水,并且类似于脂肪和油在其体内分泌行为脂蛋白,细胞脂滴细胞器和生物膜的脂质相中的作用。 这些特征在体内赋予许多独特的递送属性,特别是有利于涉及淋巴系统和肝细胞的病毒感染的治疗,但是这些特征对于治疗人和动物的病毒感染通常也是有利的 。
-
公开(公告)号:EP2991657A2
公开(公告)日:2016-03-09
申请号:EP14791918.7
申请日:2014-04-30
IPC分类号: A61K31/739 , C40B40/14 , G01N33/53 , G01N33/574 , G01N33/576 , G01N33/68
CPC分类号: G01N33/92 , C12Q1/6883 , C12Q1/707 , C12Q2600/158 , G01N2333/08 , G01N2800/26 , G01N2800/52
摘要: The present application provides novel lipidomic markers for Hepatitis C and related conditions, such as hepatic fibrosis and hepatocellular carcinoma.
摘要翻译: 丙型肝炎和相关病症的脂质体标记物,治疗肝纤维化和肝细胞癌。 给予该受试者的药剂可以是亚氨基糖苷下的细胞总脂肪酸含量,其可能对丙型肝炎有效。这种亚氨基糖苷可以是例如N-取代的脱氧缺氧神经霉素及其药学上可接受的盐之一,N-取代的脱氧半乳糖吉非霉素 和其药学上可接受的盐和N-取代的Me-脱氧半乳糖吉非霉素及其药学上可接受的盐。 评估丙型肝炎感染或由所述感染引起或与之相关的病症的方法。 该方法包括:从有需要的受试者获得生物样品; 确定所述生物样品中至少一种丙型肝炎脂质体生物标志物的水平; 并将所述水平与所述丙型肝炎脂质体生物标志物的对照水平进行比较,以评估丙型肝炎感染或由所述感染引起的或与受试者相关的病症。
-
公开(公告)号:EP2991488A2
公开(公告)日:2016-03-09
申请号:EP14791128.3
申请日:2014-04-30
发明人: LAING, Peter , DWEK, Raymond A. , POLLOCK, Stephanie , ZITZMANN, Nicole , BUTTERS, Terry , ALONZI, Dominic , KIAPPES, John , RAMSTEDT, Urban
IPC分类号: A01N43/40 , A61K31/45 , A61K31/445
CPC分类号: C07D211/46 , A61K31/445 , A61K31/45 , A61K31/453
摘要: The application provides iminosugars with a high activity and specificity for inhibiting ceramide glucosyltransferase.
-
-